421 related articles for article (PubMed ID: 23943232)
21. Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.
Ratnavelu ND; Brown AP; Mallett S; Scholten RJ; Patel A; Founta C; Galaal K; Cross P; Naik R
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD010360. PubMed ID: 26930463
[TBL] [Abstract][Full Text] [Related]
22. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.
Siristatidis CS; Vrachnis N; Creatsa M; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2013 Oct; (10):CD006606. PubMed ID: 24101529
[TBL] [Abstract][Full Text] [Related]
23. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
Zhang J; Li T; Zhou L; Tang L; Xu L; Wu T; Lim DC
Cochrane Database Syst Rev; 2010 Sep; (9):CD007535. PubMed ID: 20824862
[TBL] [Abstract][Full Text] [Related]
24. Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination.
Lensen SF; Manders M; Nastri CO; Gibreel A; Martins WP; Templer GE; Farquhar C
Cochrane Database Syst Rev; 2016 Jun; (6):CD011424. PubMed ID: 27296541
[TBL] [Abstract][Full Text] [Related]
25. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
Martins WP; Vieira AD; Figueiredo JB; Nastri CO
Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
[TBL] [Abstract][Full Text] [Related]
26. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.
Brown J; Farquhar C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002249. PubMed ID: 27976369
[TBL] [Abstract][Full Text] [Related]
27. Intra-uterine insemination for unexplained subfertility.
Veltman-Verhulst SM; Hughes E; Ayeleke RO; Cohlen BJ
Cochrane Database Syst Rev; 2016 Feb; 2():CD001838. PubMed ID: 26892070
[TBL] [Abstract][Full Text] [Related]
28. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
29. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
30. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
Youssef MA; Abou-Setta AM; Lam WS
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
Kwan I; Bhattacharya S; McNeil A; van Rumste MM
Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
[TBL] [Abstract][Full Text] [Related]
32. Intra-uterine insemination for unexplained subfertility.
Veltman-Verhulst SM; Cohlen BJ; Hughes E; Heineman MJ
Cochrane Database Syst Rev; 2012 Sep; (9):CD001838. PubMed ID: 22972053
[TBL] [Abstract][Full Text] [Related]
33. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
34. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
[TBL] [Abstract][Full Text] [Related]
35. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
36. Melanoma risk after ovarian stimulation for in vitro fertilization.
Spaan M; van den Belt-Dusebout AW; Schaapveld M; Mooij TM; Burger CW; van Leeuwen FE;
Hum Reprod; 2015 May; 30(5):1216-28. PubMed ID: 25743782
[TBL] [Abstract][Full Text] [Related]
37. Temperature of embryo culture for assisted reproduction.
Baak NA; Cantineau AE; Farquhar C; Brison DR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD012192. PubMed ID: 31529804
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.
Kalampokas T; Pandian Z; Keay SD; Bhattacharya S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004752. PubMed ID: 28349525
[TBL] [Abstract][Full Text] [Related]
39. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
[TBL] [Abstract][Full Text] [Related]
40. Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.
Craciunas L; Tsampras N; Coomarasamy A; Raine-Fenning N
Cochrane Database Syst Rev; 2016 May; (5):CD011537. PubMed ID: 27195724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
